about
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's diseaseUse of thiopurines in inflammatory bowel diseaseA controlled double blind study of azathioprine in the management of Crohn's diseaseAzathioprine pharmacokinetics after intravenous, oral, delayed release oral and rectal foam administration.Sulphasalazine in asymptomatic Crohn's disease. A multicentre trialLow dose steroids and clinical relapse in Crohn's disease: a controlled trial.Oral BCG vaccine in Crohn's disease.European evidence based consensus on the diagnosis and management of Crohn's disease: current management.Controlled trial of azathioprine in chronic ulcerative colitis.6-Mercaptopurine is effective in Crohn's disease without concomitant steroids.Randomised controlled trial of azathioprine withdrawal in ulcerative colitis.Review article: monitoring of immunomodulators in inflammatory bowel disease.Maintenance of remission in Crohn's disease.Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease.Novel approaches to inflammatory bowel disease.Thiopurine-induced liver injury in patients with inflammatory bowel disease: a systematic review.Maintenance of medically induced remission of Crohn's disease.Are we giving azathioprine too much time?Thiopurines in Crohn's disease, is there something new?Thiopurine therapy in inflammatory bowel disease.Efficacy of immunosuppressive therapy for inflammatory bowel disease: a systematic review and meta-analysis.An evidence-based systematic review on medical therapies for inflammatory bowel disease.The role and advances of immunomodulator therapy for inflammatory bowel disease.Thiopurine metabolite testing in inflammatory bowel disease.Drug therapy of inflammatory bowel disease.Azathioprine.Patients with Crohn's Disease Are More Likely to Remain on Biologics than Immunomodulators: A Meta-Analysis of Treatment Durability.Peripheral blood and mesenteric lymph node lymphocytes in Crohn's disease.Does colonoscopy cause increased ulcerative colitis symptoms?Monitoring of long-term thiopurine therapy among adults with inflammatory bowel disease.Effect of early immunomodulator use in moderate to severe pediatric Crohn disease.Everolimus for refractory Crohn's disease: a case report.Inflammatory Bowel Disease: Pathophysiology and Current Therapeutic Approaches.Corticosteroid Sparing in Inflammatory Bowel Disease is More Often Achieved in the Immunomodulator and Biological Era-Results from the Dutch Population-Based IBDSL Cohort.Liver injury in inflammatory bowel disease: long-term follow-up study of 786 patients.Inflammatory bowel diseases at the University of Chicago--early experiences: a personal historical account.The therapeutic potential of PDE4 inhibitors.Mucosal healing in pediatric Crohn's disease: the goal of medical treatment.
P2860
Q24186291-6B4D0BEF-D04D-4ADF-9075-F829131D92BDQ26824662-EB6C6F14-73DE-4017-952B-DE0C63DE3F17Q34408881-907D12FE-5D6F-490A-810E-70F3AA2A1F52Q34409942-6C3894B4-761E-43B0-A2D9-B0DB58D34AA5Q34472315-CA92F0B9-DE15-4EAB-8A20-4635217C7F6DQ34474565-0E7DA855-C92A-4886-92B0-9AADDE205B74Q34475161-8A80B69B-BA43-435C-BC0D-52F5D5C1CC9EQ34564902-0C2C04D3-5ED2-4E7C-8677-FA7CE37504A4Q34759169-EA30402D-6101-43D0-A7F9-4ACF14EF1353Q35787594-B678BA4F-2873-446F-B88D-1F783FC6F8CDQ35822294-9AF9DC11-F8DF-40D4-9C2B-63261386F111Q36041146-5706043D-F1ED-40C8-93DA-ED6C2B194D2BQ36041732-675224AF-112E-4741-A734-85CF8A02894CQ36175167-C61E07EE-BAB1-4C6F-A48A-EA9B6D9BB3FEQ36181229-FCA8516F-1C04-4288-9B38-908943832F3DQ36772955-B582A966-6583-4E25-AEF6-4A67EBEA1107Q37073410-10089235-A6BF-4D4A-A286-D9D0C0357CB7Q37276966-9300426A-1C2B-46C6-87EF-2DA205E228AEQ37797517-E1218260-EB98-4CEA-B802-F5227409D920Q37798819-A7E38802-B514-46FB-9C92-CA20AC44C1DFQ37853360-86D494D6-5F1F-4039-B402-7E71ABE29472Q37862584-06152543-5316-4A7E-B30D-CF9F73838325Q38237701-E3AB2226-D8A3-4F99-9603-D6C997126ED7Q38618602-F181556F-88F6-4A4D-B68E-B99D0F1B67F9Q40090889-F16A8F87-D562-4157-9E9E-CF4A049AECEBQ40316465-49A1ECFE-8ABA-4AA8-B063-DD517E064592Q41219043-0547A001-D0AD-4CFC-852D-7362155C1A4DQ42067182-226BFA39-7552-4DB9-899D-39623EC40801Q44925957-B3987736-FA28-4A25-8A1A-08904443B7A8Q45151580-03BDE46E-7C92-4BD4-9A4E-4FF66EC789A4Q46728960-246EFAF7-1253-4E97-9E78-2292F9DCC48EQ46753802-85259747-159B-4675-9D89-E41E08BC554EQ47961270-73DF403F-9D2E-4D9C-8A72-1C8F5749B46CQ50111610-FBB71FE4-ECE5-45A9-8A20-AF61C245E297Q51916542-F3B76D2E-747F-4C3C-92F9-A4D01D7933C7Q53302997-30CF9450-D986-4F5F-BD06-3581941B08B5Q53619316-757EE614-E011-4F8B-B78D-21012756A1EFQ53883128-653844D8-556C-4183-A64B-681967CD0D77
P2860
description
1975 nî lūn-bûn
@nan
1975 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
1975 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
1975年の論文
@ja
1975年論文
@yue
1975年論文
@zh-hant
1975年論文
@zh-hk
1975年論文
@zh-mo
1975年論文
@zh-tw
1975年论文
@wuu
name
A controlled trial of azathioprine in Crohn's disease
@ast
A controlled trial of azathioprine in Crohn's disease
@en
A controlled trial of azathioprine in Crohn's disease
@nl
type
label
A controlled trial of azathioprine in Crohn's disease
@ast
A controlled trial of azathioprine in Crohn's disease
@en
A controlled trial of azathioprine in Crohn's disease
@nl
prefLabel
A controlled trial of azathioprine in Crohn's disease
@ast
A controlled trial of azathioprine in Crohn's disease
@en
A controlled trial of azathioprine in Crohn's disease
@nl
P2093
P356
P1476
A controlled trial of azathioprine in Crohn's disease
@en
P2093
J B Kirsner
J L Rosenberg
P356
10.1007/BF01070829
P407
P577
1975-08-01T00:00:00Z